CCM vs. PIII, BNR, ENZ, OPGN, MRAI, BRTX, KDLY, MGRX, SSY, and OTRK
Should you be buying Concord Medical Services stock or one of its competitors? The main competitors of Concord Medical Services include P3 Health Partners (PIII), Burning Rock Biotech (BNR), Enzo Biochem (ENZ), OpGen (OPGN), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), SunLink Health Systems (SSY), and Ontrak (OTRK). These companies are all part of the "healthcare" industry.
Concord Medical Services vs.
Concord Medical Services (NYSE:CCM) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.
Concord Medical Services received 193 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 59.52% of users gave Concord Medical Services an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote.
P3 Health Partners has a consensus target price of $0.25, indicating a potential upside of 38.27%. Given P3 Health Partners' stronger consensus rating and higher possible upside, analysts plainly believe P3 Health Partners is more favorable than Concord Medical Services.
7.8% of P3 Health Partners shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by company insiders. Comparatively, 15.8% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
In the previous week, P3 Health Partners had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 3 mentions for P3 Health Partners and 2 mentions for Concord Medical Services. P3 Health Partners' average media sentiment score of 0.30 beat Concord Medical Services' score of -0.50 indicating that P3 Health Partners is being referred to more favorably in the news media.
Concord Medical Services has a net margin of 0.00% compared to P3 Health Partners' net margin of -6.95%. Concord Medical Services' return on equity of 0.00% beat P3 Health Partners' return on equity.
Concord Medical Services has a beta of -0.49, indicating that its share price is 149% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.
Concord Medical Services has higher earnings, but lower revenue than P3 Health Partners.
Summary
P3 Health Partners beats Concord Medical Services on 9 of the 16 factors compared between the two stocks.
Get Concord Medical Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Concord Medical Services Competitors List
Related Companies and Tools
This page (NYSE:CCM) was last updated on 3/28/2025 by MarketBeat.com Staff
Buy CCM Stock Free CCM Stock Alerts